The content on this site is intended for healthcare professionals only
The timeline of adjuvant and neoadjuvant therapy for melanoma
Effects of ultraviolet light on underlying genes behind at-risk phenotypes
Metabolic regulation of melanoma cells
Targeted therapies in melanoma
Causes, symptoms, and prevention of skin cancer
Treatment of cutaneous T cell lymphoma
Skin cancer lesions arising in uncommon regions
Developments in checkpoint immunotherapy
Targetted medicine to reduce melanoma mutational burden
VISMO trial to treat basal cell carcinoma
Checkpoint inhibitor therapy for treating melanoma
Metabolomics: Reversing drug resistance
